Literature DB >> 25065169

[Psoriasis. Inhibition of IL-17 signaling pathway by Secukinumab].

Katrina Recker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25065169

Source DB:  PubMed          Journal:  Med Monatsschr Pharm        ISSN： 0342-9601


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of secukinumab in the treatment of moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.

Authors:  Hui-Zi Xiong; Jun-Ying Gu; Zhi-Gang He; Wen-Juan Chen; Xiao Zhang; Jia-Yi Wang; Yu-Ling Shi
Journal:  Int J Clin Exp Med       Date:  2015-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.